- Previous Close
2.4200 - Open
2.4100 - Bid 2.4000 x 100
- Ask 2.2400 x 100
- Day's Range
2.2100 - 2.4100 - 52 Week Range
2.0940 - 4.0100 - Volume
13,711 - Avg. Volume
82,390 - Market Cap (intraday)
22.463M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
www.gelteq.com7
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: GELS
View More
Performance Overview: GELS
Trailing total returns as of 11/12/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GELS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GELS
View MoreValuation Measures
Market Cap
21.80M
Enterprise Value
23.97M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.04
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-7.43%
Return on Equity (ttm)
-18.75%
Revenue (ttm)
131.76k
Net Income Avi to Common (ttm)
-3.36M
Diluted EPS (ttm)
-0.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
399.22k
Total Debt/Equity (mrq)
13.34%
Levered Free Cash Flow (ttm)
-463.5k
Company Insights: GELS
GELS does not have Company Insights